DrugPatentWatch Database Preview
« Back to Dashboard
Summary for Patent: 7,351,414
|Title:||Method of reducing the risk of bone fracture|
|Abstract:||The invention relates to a method for increasing the toughness and/or stiffness of bone and/or reducing the likelihood and/or severity of bone fracture by administering a parathyroid hormone. The method can be employed to increase toughness or stiffness of bone at a site of a potential or actual trauma, such as the hip or spine of a person at risk of or suffering from osteoporosis. The method of the invention can reduce the incidence of vertebral fracture, reduce the incidence of multiple vertebral fractures, reduce the severity of vertebral fractur and/or reduce the incidence of non-vertebral fracture.|
|Inventor(s):||Gaich; Gregory A. (Indianapolis, IN), Dere; Willard H. (Westlake Village Ventura, CA), Hock; Janet M. (Indianapolis, IN)|
|Assignee:||Eli Lilly and Company (Indianapolis, IN)|
1. A method for the treatment of a woman with osteoporosis and at risk for bone fracture comprising administering to said woman human parathyroid hormone (1-34) in a daily dose of 20
.mu.g, without concurrent administration of an antiresorptive agent other than vitamin D or calcium, said treatment reducing the risk of vertebral and nonvertebral bone fracture.
2. The method of claim 1, wherein the osteoporosis is selected from advanced-stage osteoporosis, spinal osteoporosis, and steroid-induced osteoporosis.
3. A method for the treatment of a man with osteoporosis and at risk for bone fracture comprising administering to said man human parathyroid hormone (1-34) in a daily dose of 20 .mu.g, without concurrent administration of an antiresorptive agent other than vitamin D or calcium, said treatment reducing the risk of vertebral and non-vertebral bone fracture.
4. The method of claim 3 in which said man has hypogonadal osteoporosis.
For more information try a trial or see the plans and pricing
Serving hundreds of leading biopharmaceutical companies globally: